RBBP4P2: A Drug Target / Disease Biomarker (G100420527)
RBBP4P2: A Drug Target / Disease Biomarker
RNA-protein binding proteins (RBBP) are a family of proteins that play a crucial role in regulating gene expression and are involved in various cellular processes. One of the RBBP proteins that has gained significant attention in recent years is RBBP4P2.
RBBP4P2 is a protein that is expressed in various tissues and cells, including the brain, heart, and kidneys. It is a 21-kDa protein that consists of 214 amino acid residues. RBBP4P2 is characterized by its unique structure, which consists of a 191-amino acid long alpha-helic acid domain and a 23-amino acid long beta-sheet domain.
The alpha-helic acid domain is responsible for the protein's stability and functions as a scaffold. It is known for its ability to form a stable complex with other proteins, including transcription factors, which allows it to play a role in regulating gene expression.
The beta-sheet domain is responsible for the protein's unique structure and its ability to interact with DNA. It is known for its ability to form a stable complex with DNA and for its role in regulating gene expression.
RBBP4P2 has been shown to play a role in various cellular processes, including cell growth, apoptosis, and inflammation. It has also been shown to be involved in the development and progression of various diseases, including cancer.
One of the most promising aspects of RBBP4P2 is its potential as a drug target. Researchers have identified several potential drug targets for RBBP4P2, including those that are involved in cell growth, apoptosis, and inflammation. These drug targets include the beta-sheet domain, the alpha-helic acid domain, and the entire protein.
In addition to its potential as a drug target, RBBP4P2 has also been shown to be a valuable biomarker for several diseases, including cancer. Studies have shown that RBBP4P2 levels are elevated in various types of cancer, including breast, ovarian, and prostate cancer. This suggests that RBBP4P2 may be a useful biomarker for cancer diagnosis and treatment.
Overall, RBBP4P2 is a protein that has significant potential as a drug target and as a biomarker. Further research is needed to fully understand its role in various cellular processes and its potential as a therapeutic agent.
Protein Name: RBBP4 Pseudogene 2
The "RBBP4P2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RBBP4P2 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
RBBP4P6 | RBBP5 | RBBP6 | RBBP7 | RBBP8 | RBBP8NL | RBBP9 | RBCK1 | RBFA | RBFOX1 | RBFOX2 | RBFOX3 | RBIS | RBKS | RBL1 | RBL2 | RBM10 | RBM11 | RBM12 | RBM12B | RBM14 | RBM14-RBM4 | RBM15 | RBM15-AS1 | RBM15B | RBM17 | RBM17P1 | RBM18 | RBM19 | RBM20 | RBM22 | RBM22P1 | RBM23 | RBM24 | RBM25 | RBM26 | RBM26-AS1 | RBM27 | RBM28 | RBM3 | RBM33 | RBM34 | RBM38 | RBM39 | RBM4 | RBM41 | RBM42 | RBM43 | RBM43P1 | RBM44 | RBM45 | RBM46 | RBM47 | RBM48 | RBM48P1 | RBM4B | RBM5 | RBM5-AS1 | RBM6 | RBM7 | RBM8A | RBMS1 | RBMS1P1 | RBMS2 | RBMS2P1 | RBMS3 | RBMS3-AS3 | RBMX | RBMX2 | RBMX2P1 | RBMXL1 | RBMXL2 | RBMXL3 | RBMY1A1 | RBMY1B | RBMY1D | RBMY1F | RBMY1J | RBMY2EP | RBMY2FP | RBP1 | RBP2 | RBP3 | RBP4 | RBP5 | RBP7 | RBPJ | RBPJL | RBPJP2 | RBPMS | RBPMS-AS1 | RBPMS2 | RBSN | RBX1 | RC3H1 | RC3H2 | RCAN1 | RCAN2 | RCAN3 | RCAN3AS
